Prognosis in childhood and adult acute lymphoblastic leukaemia: a question of maturation?

被引:55
作者
Plasschaert, SLA
Kamps, WA
Vellenga, E
de Vries, EGE
de Bont, ESJM
机构
[1] Univ Groningen Hosp, Dept Paediat Haematol & Oncol, NL-9713 GZ Groningen, Netherlands
[2] Univ Groningen Hosp, Dept Haematol, NL-9713 GZ Groningen, Netherlands
[3] Univ Groningen Hosp, Dept Med Oncol, NL-9713 GZ Groningen, Netherlands
关键词
D O I
10.1016/S0305-7372(03)00140-3
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
Acute lymphoblastic leukaemia (ALL) is a disease diagnosed in children as well as adults. Progress in the treatment of ALL has led to better survival rates, however, children have benefited more from improved treatment modalities than adults. Recent evidence has underscored that the difference in characteristics and biology of adult versus childhood ALL might be the result of a different origin. According to the two-hit paradigm of Knudson, to develop cancer two genetic events are necessary. It has been suggested, that in childhood ALL the first genetic event happens in the more mature lymphoid committed progenitor cells, whereas in adult ALL the first hit occurs in multipotent stem cells. This review compares patient characteristics, the extent of the disease, leukaemic cell characteristics and treatment between childhood and adult ALL. This is discussed in relation to the hypothesis that the maturation stage of the cells, from which the leukaemia arises, is responsible for the differential behaviour of adult and childhood ALL. (C) 2003 Elsevier Ltd. All rights reserved.
引用
收藏
页码:37 / 51
页数:15
相关论文
共 157 条
[1]   CYTOGENETIC PATTERN IN LEUKEMIC-CELLS OF PATIENTS WITH CONSTITUTIONAL CHROMOSOME-ANOMALIES [J].
ALIMENA, G ;
BILLSTROM, R ;
CASALONE, R ;
GALLO, E ;
MITELMAN, F ;
PASQUALI, F .
CANCER GENETICS AND CYTOGENETICS, 1985, 16 (03) :207-218
[2]  
Allikmets R, 1998, CANCER RES, V58, P5337
[3]   CONSOLIDATION TREATMENT OF ADULT ACUTE LYMPHOBLASTIC-LEUKEMIA - A PROSPECTIVE, RANDOMIZED TRIAL COMPARING ALLOGENEIC VERSUS AUTOLOGOUS BONE-MARROW TRANSPLANTATION AND TESTING THE IMPACT OF RECOMBINANT INTERLEUKIN-2 AFTER AUTOLOGOUS BONE-MARROW TRANSPLANTATION [J].
ATTAL, M ;
BLAISE, D ;
MARIT, G ;
PAYEN, C ;
MICHALLET, M ;
VERNANT, JP ;
SAUVAGE, C ;
TROUSSARD, X ;
NEDELLEC, G ;
PICO, J ;
HUGUET, F ;
STOPPA, AM ;
BROUSTET, A ;
SOTTO, JJ ;
PRIS, J ;
MARANINCHI, D ;
REIFFERS, J .
BLOOD, 1995, 86 (04) :1619-1628
[4]   Translocations, cancer and the puzzle of specificity [J].
Barr, FG .
NATURE GENETICS, 1998, 19 (02) :121-124
[5]  
BASSAN R, 1995, LEUKEMIA, V9, P933
[6]   Mutation analysis of CD95 (APO-1/Fas) in childhood B-lineage acute lymphoblastic leukaemia [J].
Beltinger, C ;
Böhler, T ;
Karawajew, L ;
Ludwig, WD ;
Schrappe, M ;
Debatin, KM .
BRITISH JOURNAL OF HAEMATOLOGY, 1998, 102 (03) :722-728
[7]  
Beltinger C, 1998, BLOOD, V91, P3943
[8]   THE MORPHOLOGICAL CLASSIFICATION OF ACUTE LYMPHOBLASTIC-LEUKEMIA - CONCORDANCE AMONG OBSERVERS AND CLINICAL CORRELATIONS [J].
BENNETT, JM ;
CATOVSKY, D ;
DANIEL, MT ;
FLANDRIN, G ;
GALTON, DAG ;
GRALNICK, HR ;
SULTAN, C .
BRITISH JOURNAL OF HAEMATOLOGY, 1981, 47 (04) :553-+
[9]  
BLEYER WA, 1985, SEMIN ONCOL, V12, P131
[10]   OUTCOME PREDICTION IN CHILDHOOD ACUTE LYMPHOBLASTIC-LEUKEMIA BY MOLECULAR QUANTIFICATION OF RESIDUAL DISEASE AT THE END OF INDUCTION [J].
BRISCO, MJ ;
CONDON, J ;
HUGHES, E ;
NEOH, SH ;
SYKES, PJ ;
SESHADRI, R ;
TOOGOOD, I ;
WATERS, K ;
TAURO, G ;
EKERT, H ;
MORLEY, AA .
LANCET, 1994, 343 (8891) :196-200